ORABLOC Drug Patent Profile
✉ Email this page to a colleague
When do Orabloc patents expire, and what generic alternatives are available?
Orabloc is a drug marketed by Pierrel and is included in one NDA.
The generic ingredient in ORABLOC is articaine hydrochloride; epinephrine bitartrate. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the articaine hydrochloride; epinephrine bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ORABLOC?
- What are the global sales for ORABLOC?
- What is Average Wholesale Price for ORABLOC?
Summary for ORABLOC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 4 |
| Clinical Trials: | 1 |
| What excipients (inactive ingredients) are in ORABLOC? | ORABLOC excipients list |
| DailyMed Link: | ORABLOC at DailyMed |
Recent Clinical Trials for ORABLOC
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Taiwan University Hospital | N/A |
Pharmacology for ORABLOC
| Drug Class | Amide Local Anesthetic Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
| Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for ORABLOC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pierrel | ORABLOC | articaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 022466-001 | Feb 26, 2010 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pierrel | ORABLOC | articaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 022466-002 | Feb 26, 2010 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
